• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
David Z. Morris

Stay informed with David Z. Morris’s coverage and analysis.

One billion COVID vaccines
NewslettersThe last mile of the immunization campaign approaches
By Sy Mukherjee and David Z. MorrisApril 23, 2021
Shawmut Facility
PoliticsCOVID exposed global supply-chain flaws. Can Biden bring manufacturing back to the U.S.?
By David Z. MorrisApril 23, 2021
Skeptical of outdoor masking? Congratulations on catching up to reality.
NewslettersSkeptical of outdoor masking? Congratulations on catching up to reality.
By Sy Mukherjee and David Z. MorrisApril 22, 2021
The last mile of the immunization campaign approaches
NewslettersThe last mile of the immunization campaign approaches
By Sy Mukherjee and David Z. MorrisApril 21, 2021
Is the Bitcoin bull run over?
NewslettersIs the Bitcoin bull run over?
By David Z. Morris and Robert HackettApril 21, 2021
What’s the matter with Michigan?
NewslettersWhat’s the matter with Michigan?
By Sy Mukherjee and David Z. MorrisApril 20, 2021
A milestone for COVID vaccinations as all U.S. adults are eligible
NewslettersA milestone for COVID vaccinations as all U.S. adults are eligible
By Sy Mukherjee and David Z. MorrisApril 19, 2021
Drug development innovation
NewslettersWhat makes a drug company truly innovative?
By Sy Mukherjee and David Z. MorrisApril 16, 2021
Johnson & Johnson: The pause heard ’round the world
NewslettersJohnson & Johnson: The pause heard ’round the world
By David Z. Morris and Sy MukherjeeApril 15, 2021
Catalent COVID vaccine contract manufacturers
NewslettersThe crucial third party players in the pandemic fight
By David Z. Morris and Sy MukherjeeApril 14, 2021
Maybe Coinbase is hard to value because it’s a ‘hyperobject’
NewslettersMaybe Coinbase is hard to value because it’s a ‘hyperobject’
By David Z. Morris and Robert HackettApril 14, 2021
An abundance of caution with the Johnson & Johnson vaccine
NewslettersAn abundance of caution with the Johnson & Johnson vaccine
By David Z. Morris and Sy MukherjeeApril 13, 2021
You just got the J&J COVID vaccine. Should you be worried about the CDC’s pause recommendation?
HealthYou just got the J&J COVID vaccine. Should you be worried about the CDC’s pause recommendation?
By David Z. MorrisApril 13, 2021
Mastercard, UBS, and JPMorgan pour $65 million into Ethereum startup studio ConsenSys
The CoinsMastercard, UBS, and JPMorgan pour $65 million into Ethereum startup studio ConsenSys
By David Z. MorrisApril 13, 2021
The public health scourge we don’t talk about nearly enough
NewslettersThe public health scourge we don’t talk about nearly enough
By David Z. Morris and Sy MukherjeeApril 9, 2021
1
  • 1
  • 2
  • 3
  • 4
  • 5
...100
Most Popular
Personal Finance
I wrote that Boomers were choking America’s economy. Their responses to me were revealingplaceholder alt text
By Nick LichtenbergMay 31, 2026
Investing
If Elon Musk merges SpaceX with Tesla he'll create a $3.4 trillion behemoth—with zero profitsplaceholder alt text
By Shawn TullyMay 31, 2026
Future of Work
When loyalty is rewarded: Top earners who stay in their jobs get much larger pay increases than those who switchplaceholder alt text
By Jacqueline MunisMay 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.